Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 89 member A (FAM89A) is a human protein-coding gene located on chromosome 1. It is not currently categorized as a well-characterized therapeutic target, receptor, enzyme, transporter, or transcription factor[1][10][13]. FAM89A has few known biological functions and its molecular role remains unclear. The gene has been linked to a rare disease, "Immunodeficiency 38 with basal ganglia calcification," suggesting potential involvement in immune processes, but there are no established drug interactions, mechanisms of action, or biomarker roles[1][3][9]. Alternative names include C1orf153 and MGC15887[1][3]. There is no high-confidence evidence for canonical molecular functionality such as signal transduction, metabolism, or transcriptional regulation. FAM89A is not recognized as a validated therapeutic target and no safety or efficacy data are available[1][3][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 89 member A (FAM89A).